The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,180.00
Bid: 6,170.00
Ask: 6,200.00
Change: 160.00 (2.66%)
Spread: 30.00 (0.486%)
Open: 5,770.00
High: 6,190.00
Low: 5,770.00
Prev. Close: 6,020.00
FOUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison Investment Research Limited: 4imprint Group (FOUR) - Moving on up

1 Mar 2022 07:01

Edison Investment Research Limited Edison Investment Research Limited: 4imprint Group (FOUR) - Moving on up 01-March-2022 / 07:00 GMT/BST


 

London, UK, 1 March 2022

 

4imprint Group (FOUR) - Moving on up

4imprint's year-end trading update points to FY21 revenues of $787m, ahead of our expectation of $775m, up 41% on the prior year, after a strong Q4. PBT is indicated at the high end of the (wide) consensus range and we increase our estimate from $22.6m to $30.4m. Supply chain and inflation issues look set to continue, so margins will take longer to recover to the levels pre-COVID-19 pandemic, but the group has a degree of flexibility around substitution and pricing, which should mitigate the heaviest potential trading impact. 4imprint's long-term growth record, strong cash generation and robust balance sheet underpin the premium rating.

4imprint benefits from its scale, low fixed-cost base and limited capital requirements, attractive cash flow characteristics and cash positive balance sheet, all of which justify its premium rating. A DCF suggests a price of £33.29, while it trades on an FY22e EV/EBITDA of 21.5x, versus marketing services stocks on 10.5x. We expect continuing good growth will narrow this valuation gap.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Fiona Orford-Williams +44 (0)20 3077 5739 media@edisongroup.com

Max Hayes +44 (0)20 3077 5700 media@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn www.linkedin.com/company/edison-group-/

Twitter  www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1290081 01-March-2022 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
30th Mar 20208:32 amRNSHolding(s) in Company
26th Mar 202011:43 amRNSHolding(s) in Company
24th Mar 20203:09 pmRNSHolding(s) in Company
24th Mar 202012:02 pmRNSPrice Monitoring Extension
23rd Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 202010:15 amRNSPrice Monitoring Extension
19th Mar 20207:00 amRNSCOVID-19 Update
13th Mar 20204:36 pmRNSPrice Monitoring Extension
5th Mar 20204:25 pmRNSHolding(s) in Company
5th Mar 20208:49 amRNSHolding(s) in Company
3rd Mar 20202:38 pmRNSHolding(s) in Company
3rd Mar 20207:00 amRNSFinal Results
26th Feb 20203:55 pmRNSHolding(s) in Company
16th Jan 20207:00 amRNSTrading Update and Notice of Final Results
30th Dec 20197:00 amRNSDirectorate Change
23rd Dec 20192:53 pmRNSHolding(s) in Company
18th Dec 20192:46 pmRNSHolding(s) in Company
17th Dec 20193:01 pmRNSEBT Purchase
6th Nov 20198:30 amRNSHolding(s) in Company
5th Nov 20194:24 pmRNSEBT Purchase
4th Nov 20197:00 amRNSTrading Update
29th Oct 20199:01 amRNSEBT Purchase
25th Oct 20199:22 amRNSHolding(s) in Company
17th Oct 20193:51 pmRNSHolding(s) in Company
3rd Oct 20193:55 pmRNSHolding(s) in Company
3rd Oct 20191:14 pmRNSEBT Purchase
2nd Oct 20194:59 pmRNSHolding(s) in Company
30th Sep 201910:30 amRNSDirector/PDMR Shareholding
13th Sep 20194:38 pmRNSHolding(s) in Company
9th Sep 20199:11 amRNSEBT Purchase
27th Aug 20192:42 pmRNSDirector/PDMR Shareholding
14th Aug 20199:48 amRNSHolding(s) in Company
31st Jul 20197:00 amRNSHalf-year Report
29th Jul 20198:55 amRNSHolding(s) in Company
12th Jul 20194:28 pmRNSHolding(s) in Company
1st Jul 201910:03 amRNSDirector/PDMR Shareholding
25th Jun 20199:11 amRNSHolding(s) in Company
14th Jun 20199:25 amRNSEBT Purchase
20th May 201911:18 amRNSEBT purchase
7th May 20192:21 pmRNSResult of AGM
7th May 20197:00 amRNSAGM Statement
24th Apr 201911:56 amRNSEBT Purchase
4th Apr 201911:21 amRNSHolding(s) in Company
4th Apr 201911:09 amRNSDirector/PDMR Shareholding
3rd Apr 20198:29 amRNSHolding(s) in Company
1st Apr 20193:57 pmRNSAnnual Financial Report
28th Mar 20193:13 pmRNSDirector/PDMR Shareholding
27th Mar 20193:09 pmRNSAppointment of Independent Non-Executive Director
20th Mar 20199:32 amRNSEBT Purchase
5th Mar 20197:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.